These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16565232)

  • 1. Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria.
    Pontremoli R; Leoncini G; Viazzi F; Ratto E; Vaccaro V; Falqui V; Parodi A; Conti N; Tomolillo C; Deferrari G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S112-4. PubMed ID: 16565232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving cardiovascular risk stratification: the case for redefining microalbuminuria.
    Leoncini G; Ratto E; Viazzi F; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Nephrol; 2007; 20 Suppl 12():S51-5. PubMed ID: 18050144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of microalbuminuria in the overall risk assessment of hypertensive patients].
    Leoncini G; Ratto E; Viazzi F; Pontremoli R
    G Ital Nefrol; 2007; 24(6):565-73. PubMed ID: 18278760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microalbuminuria as an early marker for cardiovascular disease.
    de Zeeuw D; Parving HH; Henning RH
    J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring and managing urinary albumin excretion: practical advice for primary care clinicians.
    Bakris GL; Kuritzky L
    Postgrad Med; 2009 Jul; 121(4):51-60. PubMed ID: 19641270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria and cardiovascular risk.
    Karalliedde J; Viberti G
    Am J Hypertens; 2004 Oct; 17(10):986-93. PubMed ID: 15485765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary albumin and cardiovascular profile in the middle-aged population.
    Cirillo M; Lombardi C; Bilancio G; Chiricone D; Stellato D; De Santo NG
    Semin Nephrol; 2005 Nov; 25(6):367-71. PubMed ID: 16298257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertension.
    Pontremoli R; Viazzi F; Sofia A; Tomolillo C; Ruello N; Bezante GP; Del Sette M; Martinoli C; Lotti R; Sacchi G; Deferrari G
    Kidney Int Suppl; 1997 Dec; 63():S163-5. PubMed ID: 9407448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progressive pathway of microalbuminuria: from early marker of renal damage to strong cardiovascular risk predictor.
    Cerasola G; Cottone S; Mulè G
    J Hypertens; 2010 Dec; 28(12):2357-69. PubMed ID: 20842046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global risk stratification in primary hypertension: the role of the kidney.
    Leoncini G; Ratto E; Viazzi F; Conti N; Falqui V; Parodi A; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Mar; 26(3):427-32. PubMed ID: 18300851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria: do we need a new threshold?
    Zamora CR; Cubeddu LX
    J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of microalbuminuria as a cardiovascular risk indicator: A review.
    Diercks GF; van Boven AJ; Hillege JL; de Jong PE; Rouleau JL; van Gilst WH
    Can J Cardiol; 2002 May; 18(5):525-35. PubMed ID: 12032579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk? The HUNT Study, Norway.
    Kvenild K; Romundstad S; Midthjell K; Krüger O; Hallan H; Holmen J
    Scand J Prim Health Care; 2006 Sep; 24(3):145-53. PubMed ID: 16923623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microalbuminuria--a valuable diagnostic parameter].
    Feldt-Rasmussen BF; Borch-Johnsen K; Deckert T; Jensen G; Jensen JS
    Ugeskr Laeger; 1993 Dec; 155(51):4149-54. PubMed ID: 8273236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microalbuminuria and cardiovascular disease.
    Weir MR
    Clin J Am Soc Nephrol; 2007 May; 2(3):581-90. PubMed ID: 17699466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary albumin excretion and coronary artery disease].
    Cirillo M; Stellato D; Lombardi C; Bilancio G; Chiricone D; De Santo NG
    G Ital Nefrol; 2006; 23 Suppl 34():S11-5. PubMed ID: 16633988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microalbuminuria--underestimated cardiovascular risk factor].
    Nowicki M; Smoleń E; Szklarek M
    Przegl Lek; 2005; 62 Suppl 2():15-8. PubMed ID: 16623111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension.
    Pedrinelli R; Dell'Omo G; Di Bello V; Pontremoli R; Mariani M
    J Hum Hypertens; 2002 Feb; 16(2):79-89. PubMed ID: 11850764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria: a useful marker of cardiovascular disease.
    Jarraya F; Lakhdar R; Kammoun K; Mahfoudh H; Drissa H; Kammoun S; Abid M; Hachicha J
    Iran J Kidney Dis; 2013 May; 7(3):178-86. PubMed ID: 23689147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.